S. 3922: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2026
This bill, titled the Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2026, aims to amend existing laws regarding tobacco products, particularly focusing on traditional and premium cigars.
Key Provisions of the Bill
- Exemption for Traditional and Premium Cigars: The bill proposes that the Food and Drug Administration (FDA) will not have the authority to regulate traditional large and premium cigars. This means that such cigars would be exempt from most provisions of the Federal Food, Drug, and Cosmetic Act.
- Definition of Traditional Large and Premium Cigars: The bill provides a specific definition of what constitutes a traditional large and premium cigar. These cigars are defined as those that:
- Are wrapped in 100% leaf tobacco.
- Contain 100% tobacco filler.
- Do not include a filter, tip, or non-tobacco mouthpiece.
- Weigh at least 6 pounds per 1,000 count.
- Are either hand-rolled or produced using a specific machine process with human involvement.
- No Additional Regulations: The bill states that no additional regulations concerning traditional large and premium cigars can be issued by the Secretary of Health and Human Services.
- Conforming Amendments: Amendments will be made to existing laws to clarify that traditional large and premium cigars are excluded from certain provisions and user fees that apply to other tobacco products.
Intended Effects
The primary intent of the bill is to protect jobs and the small business sector involved in the manufacturing, sale, and distribution of traditional and premium cigars. By exempting these products from FDA regulation, the bill seeks to ensure that the market for traditional cigars can continue to operate without the same regulatory burdens faced by other tobacco products.
Conclusion
This legislation would therefore have significant implications for the cigar industry in the U.S., specifically benefiting businesses that focus on traditional and premium cigars by reducing regulatory scrutiny and potential compliance costs.
Relevant Companies
- PM (Philip Morris International Inc.) - As a major player in the tobacco industry, this company could be impacted by the delineation of traditional large and premium cigars from other products, potentially allowing it to expand its focus on this category without stringent regulations.
- IMB (Imperial Brands PLC) - Similar to Philip Morris, Imperial Brands may benefit from reduced regulatory oversight of its traditional cigar lines, allowing for increased sales and marketing flexibility.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Feb. 25, 2026 | Introduced in Senate |
| Feb. 25, 2026 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.